Korro Bio (KRRO) Share-based Compensation Growth (3y) (2021 - 2026)
Korro Bio (KRRO) Share-based Compensation Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 244.08% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -50.27% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | 98.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.53% |
| Dec 31, 2025 | 28.97% |
| Sep 30, 2025 | -31.16% |
| Jun 30, 2025 | -24.07% |
| Mar 31, 2025 | -30.59% |
| Dec 31, 2024 | -35.95% |
| Sep 30, 2024 | -39.97% |
| Jun 30, 2024 | -45.85% |
| Mar 31, 2024 | -42.75% |
| Dec 31, 2023 | -65.92% |
| Sep 30, 2023 | -46.53% |
| Jun 30, 2023 | -45.01% |
| Mar 31, 2023 | -45.56% |
| Dec 31, 2022 | -143.23% |
| Sep 30, 2022 | 82.20% |
| Jun 30, 2022 | 45.49% |
| Mar 31, 2022 | 375.44% |
| Dec 31, 2021 | 201.72% |
| Sep 30, 2021 | 286.43% |